Reactivation of Inactive Blood Donors
NCT03366441 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11880
Last updated 2018-11-14
Summary
Blood donor retention is a critical strategy to ensure the safety and sufficiency of clinical blood supply. An effective strategy can prevent donors from lapsing and eventually becoming inactive.
Conditions
- Blood Donor
Interventions
- OTHER
-
Telephone call
From 20 October to 10 November 2016, telephone calls were given to the donors in the phone call group
- OTHER
-
SMS
Text messages were sent to an equal number of donors in the SMS group
Sponsors & Collaborators
-
Guangzhou Blood Center
lead OTHER_GOV
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-10-20
- Primary Completion
- 2017-11-10
- Completion
- 2017-12-05
Countries
- China
Study Locations
More Related Trials
-
Effect of Indication Based Blood Product Transfusion in Patients Undergoing Major Oncological Surgery
NCT05607940 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot Study
NCT03086252 ·Status: WITHDRAWN ·Phase: NA
-
Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases
NCT06294691 ·Status: RECRUITING ·Phase: PHASE3
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
NCT01492036 ·Status: RECRUITING
-
Abnormal Glucose Tolerance in Allogeneic Hematopoietic Stem Cell Transplantation
NCT06704542 ·Status: NOT_YET_RECRUITING
-
Effect of NAC on the Hematopoietic Reconstitution After Haploidentical Hematopoietic Stem Cell Transplantation
NCT03236220 ·Status: COMPLETED ·Phase: PHASE2
-
Home Transfusion for HEME
NCT05509439 ·Status: COMPLETED ·Phase: NA
-
Immunomodulation Effect of Blood Transfusion
NCT02140216 ·Status: COMPLETED
-
ACT to Reduce Morbidity and Mortality in Hematopoietic Stem Cell Transplant (HCT) Patients
NCT04423939 ·Status: COMPLETED ·Phase: NA
-
Effect of BM-MSCs in DCD Kidney Transplantation
NCT02561767 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study Comparing G-CSF Mobilized Peripheral Blood and G-CSF Stimulated Bone Marrow in Patients Undergoing Matched Sibling Transplantation
NCT01530581 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Auto-FMT in Preventing aGVHD
NCT04745221 ·Status: RECRUITING ·Phase: NA
-
Retention of Bone Marrow Donors in a National Registry
NCT00005556 ·Status: COMPLETED
-
Risk Stratification-directed NAC for Prevention of Poor Hematopoietic Reconstitution
NCT03967665 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study to Evaluate the Safety and Efficacy of ET-01 Transplantation in Subjects with Transfusion Dependent Β-Thalassaemia.
NCT05752123 ·Status: TERMINATED ·Phase: NA
-
Role of aGVHD Biomarkers on aGVHD Risks
NCT04284904 ·Status: COMPLETED
-
Iron Overload in Patients Undergoing Donor Stem Cell Transplant
NCT00888316 ·Status: COMPLETED
-
Modified Transplantation Regimen and aGVHD Prophylaxis for Severe Aplastic Anemia in the Setting of Allogeneic HSCT.
NCT06837987 ·Status: COMPLETED
-
Risk of Hepatitis B Reactivation After Bone Marrow Transplantation With Prior Hepatitis B Virus (HBV) Exposure
NCT01481649 ·Status: COMPLETED
-
MRD Monitoring by Digital Droplet PCR in the Early Period After Allo-HSCT to Predict Patients at High Risk of Relapse
NCT06000306 ·Status: COMPLETED
-
T-Cell Depletion in Unrelated Donor Marrow Transplantation
NCT00000591 ·Status: COMPLETED ·Phase: PHASE3
-
Precision Medicine for Stem Cell Transplantation
NCT05567289 ·Status: RECRUITING
-
Glutamine Popsicles in Bone Marrow Transplant (BMT)/Hematopoietic Stem Cell Transplant (HSCT) Patients
NCT00204958 ·Status: COMPLETED ·Phase: PHASE4
-
Cord Blood Microtransplantation for Treatment of Acute Myeloid Leukemia
NCT04174586 ·Status: UNKNOWN ·Phase: PHASE1
-
Haplo-PBSC+Cord vs Haplo-PBSC+BM for Hematological Malignancies Undergoing Allo-HSCT
NCT05290545 ·Status: COMPLETED ·Phase: PHASE3